chr7-150996468-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000603.5(NOS3):​c.335G>A​(p.Arg112Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00293 in 1,590,136 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 45 hom., cov: 26)
Exomes 𝑓: 0.0018 ( 42 hom. )

Consequence

NOS3
NM_000603.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.275

Publications

18 publications found
Variant links:
Genes affected
NOS3 (HGNC:7876): (nitric oxide synthase 3) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025461912).
BP6
Variant 7-150996468-G-A is Benign according to our data. Variant chr7-150996468-G-A is described in ClinVar as Benign. ClinVar VariationId is 1182440.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0144 (2101/146008) while in subpopulation AFR AF = 0.0499 (1945/38956). AF 95% confidence interval is 0.0481. There are 45 homozygotes in GnomAd4. There are 1011 alleles in the male GnomAd4 subpopulation. Median coverage is 26. This position passed quality control check.
BS2
High AC in GnomAd4 at 2101 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOS3NM_000603.5 linkc.335G>A p.Arg112Gln missense_variant Exon 4 of 27 ENST00000297494.8 NP_000594.2 P29474-1
NOS3NM_001160111.1 linkc.335G>A p.Arg112Gln missense_variant Exon 3 of 14 NP_001153583.1 P29474-2
NOS3NM_001160110.1 linkc.335G>A p.Arg112Gln missense_variant Exon 3 of 14 NP_001153582.1 P29474-3
NOS3NM_001160109.2 linkc.335G>A p.Arg112Gln missense_variant Exon 3 of 14 NP_001153581.1 P29474A0S0A6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOS3ENST00000297494.8 linkc.335G>A p.Arg112Gln missense_variant Exon 4 of 27 1 NM_000603.5 ENSP00000297494.3 P29474-1
NOS3ENST00000484524.5 linkc.335G>A p.Arg112Gln missense_variant Exon 3 of 14 1 ENSP00000420215.1 P29474-2
NOS3ENST00000467517.1 linkc.335G>A p.Arg112Gln missense_variant Exon 3 of 14 1 ENSP00000420551.1 P29474-3
NOS3ENST00000461406.5 linkc.-37+1154G>A intron_variant Intron 2 of 23 2 ENSP00000417143.1 E7ESA7

Frequencies

GnomAD3 genomes
AF:
0.0144
AC:
2100
AN:
145902
Hom.:
45
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.0500
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00698
Gnomad ASJ
AF:
0.000583
Gnomad EAS
AF:
0.000621
Gnomad SAS
AF:
0.000901
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000376
Gnomad OTH
AF:
0.0106
GnomAD2 exomes
AF:
0.00391
AC:
848
AN:
216676
AF XY:
0.00309
show subpopulations
Gnomad AFR exome
AF:
0.0541
Gnomad AMR exome
AF:
0.00289
Gnomad ASJ exome
AF:
0.000215
Gnomad EAS exome
AF:
0.0000600
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000554
Gnomad OTH exome
AF:
0.00258
GnomAD4 exome
AF:
0.00177
AC:
2559
AN:
1444128
Hom.:
42
Cov.:
34
AF XY:
0.00156
AC XY:
1120
AN XY:
716674
show subpopulations
African (AFR)
AF:
0.0516
AC:
1710
AN:
33170
American (AMR)
AF:
0.00363
AC:
154
AN:
42408
Ashkenazi Jewish (ASJ)
AF:
0.000117
AC:
3
AN:
25726
East Asian (EAS)
AF:
0.00125
AC:
49
AN:
39120
South Asian (SAS)
AF:
0.000167
AC:
14
AN:
83960
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50640
Middle Eastern (MID)
AF:
0.00453
AC:
26
AN:
5740
European-Non Finnish (NFE)
AF:
0.000354
AC:
391
AN:
1103626
Other (OTH)
AF:
0.00355
AC:
212
AN:
59738
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
126
253
379
506
632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0144
AC:
2101
AN:
146008
Hom.:
45
Cov.:
26
AF XY:
0.0143
AC XY:
1011
AN XY:
70890
show subpopulations
African (AFR)
AF:
0.0499
AC:
1945
AN:
38956
American (AMR)
AF:
0.00697
AC:
102
AN:
14628
Ashkenazi Jewish (ASJ)
AF:
0.000583
AC:
2
AN:
3428
East Asian (EAS)
AF:
0.000623
AC:
3
AN:
4816
South Asian (SAS)
AF:
0.000677
AC:
3
AN:
4432
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10002
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.000376
AC:
25
AN:
66566
Other (OTH)
AF:
0.0105
AC:
21
AN:
2006
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
85
170
254
339
424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00626
Hom.:
27
Bravo
AF:
0.0173
ESP6500AA
AF:
0.0449
AC:
194
ESP6500EA
AF:
0.000586
AC:
5
ExAC
AF:
0.00454
AC:
543

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NOS3-related disorder Benign:1
May 14, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T;.;.
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.84
T;T;T
MetaRNN
Benign
0.0025
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L;L;L
PhyloP100
0.28
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.94
N;N;N
REVEL
Benign
0.050
Sift
Benign
0.57
T;T;T
Sift4G
Benign
0.46
T;T;T
Polyphen
0.79
P;.;.
Vest4
0.12
MVP
0.49
MPC
0.073
ClinPred
0.0075
T
GERP RS
3.9
Varity_R
0.080
gMVP
0.43
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3918166; hg19: chr7-150693556; API